More Bad News For Novartis Blood Pressure Drug

In the last few days more bad news about valsartan (Diovan, Novartis) has emerged in Japan. Another major study conducted in Japan– the Jikei Heart Study– will be retracted and Japanese health authorities said they were investigating severe skin reactions associated with use of the drug. The new events are only the latest problems for the drug and Novartis… Click here to read the full story on Forbes.  

Source: CardioBrief - July 30, 2013 Category: Cardiology Authors: Larry Husten Tags: Uncategorized Source Type: blogs